Recombinant MUC1 (Gatipotuzumab Biosimilar) antibody
Quick Overview for Recombinant MUC1 (Gatipotuzumab Biosimilar) antibody (ABIN7581577)
Target
Antibody Type
Reactivity
Host
Clonality
Conjugate
Application
-
-
Expression System
- CHO Cells
-
Purpose
- Anti-MUC1 Reference Antibody (gatipotuzumab)
-
Sequence
- EVQLVESGGG LVQPGGSMRL SCVASGFPFS NYWMNWVRQA PGKGLEWVGE IRLKSNNYTT HYAESVKGRF TISRDDSKNS LYLQMNSLKT EDTAVYYCTR HYYFDYWGQG TLVTVSSAST KGPSVFPLAP SSKSTSGGTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF PAVLQSSGLY SLSSVVTVPS SSLGTQTYIC NVNHKPSNTK VDKKVEPKSC DKTHTCPPCP APELLGGPSV FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVKFNWYVD GVEVHNAKTK PREEQYNSTY RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK GQPREPQVYT LPPSRDELTK NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSKL TVDKSRWQQG NVFSCSVMHE GLHNHYTQKS LSLSPGK,DIVMTQSPLS NPVTPGEPAS ISCRSSKSLL HSNGITYFFW YLQKPGQSPQ LLIYQMSNLA SGVPDRFSGS GSGTDFTLRI SRVEAEDVGV YYCAQNLELP PTFGQGTKVE IKRTVAAPSV FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
-
Characteristics
- Anti-MUC1 Reference Antibody (gatipotuzumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
-
Purity
- >95 %
-
Isotype
- IgG1
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
Therapeutic Agents by Target and Mechanism: MUC1 regulators, ADCC
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- 1 mg/mL
-
Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
Storage
- 4 °C,-80 °C
-
Storage Comment
- +4°C,-80°C
-
-
- MUC1 (Gatipotuzumab Biosimilar)
-
Target Type
- Biosimilar
-
Molecular Weight
- 145.5 kDa
-
UniProt
- P15941
Target
-